In conclusion, our findings indicate that Mel enhances the anti‐GBM efficacy of TMZ through dual mechanisms: inhibition of the NF‐κB/COX‐2 signalling axis and induction of caspase‐3‐mediated apoptosis via a mitochondria‐independent pathway (Figure 9). The gene discussed is NFKB1; the disease is glioblastoma.